Join
Live feed
·
PRReleasevia Quantisnow
Aurinia Pharmaceuticals Inc logo

Concerned Shareholders of Aurinia Pharmaceuticals Announce Their Intention to Withhold Support for CEO Peter Greenleaf at 2025 Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
AUPH· Aurinia Pharmaceuticals Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AUPH (Aurinia Pharmaceuticals Inc) and more on Quantisnow.